Buck Wealth Strategies’s Immunic IMUX Stock Holding History

Buck Wealth Strategies’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-45	Closed	-$662	–	197
2023 Q3	$662	Buy	+45	New	+$865	﹤0.01%	342

Other funds holding IMUX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Buck Wealth Strategies's IMUX Position: Q4 2023 in Review

Buck Wealth Strategies sold out of Immunic (IMUX) in Q4 2023, closing a stake of 45 shares — an estimated $662 sold.

Buck Wealth Strategies first reported a position in IMUX in Q3 2023 and held it in 1 quarter. The position peaked at $662 in Q3 2023. 49 funds tracked by Wall St. Rank hold IMUX as of Q4 2023.

Buck Wealth Strategies reported no remaining Immunic position as of Q4 2023 after selling out during the quarter.
Buck Wealth Strategies sold 45 Immunic shares in Q4 2023, an estimated $662.
Buck Wealth Strategies first reported a position in Immunic in Q3 2023 and held it in 1 quarter.
Buck Wealth Strategies's Immunic position peaked at $662 in Q3 2023.
49 funds tracked by Wall St. Rank held Immunic as of Q4 2023.

Based on Buck Wealth Strategies's 13F filing for Q4 2023, filed 23 Jan 2024.